Form 8-K - Current report:
SEC Accession No. 0001628280-25-056077
Filing Date
2025-12-09
Accepted
2025-12-09 16:15:39
Documents
16
Period of Report
2025-12-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blln-20251209.htm   iXBRL 8-K 32856
2 EX-99.1 a991blln-earningspressrele.htm EX-99.1 148600
3 EX-99.2 a992blln-earningspressrele.htm EX-99.2 9670
7 bllnlogoa.jpg GRAPHIC 7830
8 image_0.jpg GRAPHIC 7830
  Complete submission text file 0001628280-25-056077.txt   349227

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blln-20251209.xsd EX-101.SCH 1797
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blln-20251209_lab.xml EX-101.LAB 22516
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blln-20251209_pre.xml EX-101.PRE 13053
18 EXTRACTED XBRL INSTANCE DOCUMENT blln-20251209_htm.xml XML 2826
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 650-460-2551
BillionToOne, Inc. (Filer) CIK: 0002070849 (see all company filings)

EIN.: 811082020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42934 | Film No.: 251559244
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)